Skip to main content
. 2015 Jul 14;6(29):27566–27579. doi: 10.18632/oncotarget.4491

Figure 3. Liver metastasis of a neuroendocrine tumor (G2, Ki-67: 4%); immunohistochemistry, counterstaining with hematoxylin; original magnification: x400.

Figure 3